structure nanobody-stabilized active state beta2 adrenoceptor 
g protein coupled receptors gpcrs exhibit spectrum functional behaviours response natural synthetic ligands recent crystal structures provide insights inactive states several gpcrs efforts obtain agonist-bound active-state gpcr structure proven difficult due inherent instability state absence g protein generated camelid antibody fragment nanobody human beta2 adrenergic receptor beta2ar exhibits g protein-like behaviour obtained agonist-bound active-state crystal structure receptor-nanobody complex comparison inactive beta2ar structure reveals subtle changes binding pocket; however small changes associated angstrom outward movement cytoplasmic end transmembrane segment rearrangements transmembrane segments remarkably similar observed opsin active form rhodopsin structure provides insights process agonist binding activation 
